Recall Enforment Report D-0270-2025

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Breckenridge Pharmaceutical, Inc., originally initiated on 02-28-2025 for the product Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10 The product was recalled due to cgmp deviations: presence of n-nitroso-duloxetine impurity above fda recommended interim limit.. The product was distributed nationwide and the recall is currently ongoing.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0270-202502-28-202503-19-2025Class II14,749 bottles.Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-747-10CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Ongoing
D-0271-202502-28-202503-19-2025Class II11,125 bottles.Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-746-05CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Ongoing
D-0269-202502-28-202503-19-2025Class II11,100 bottles.Duloxetine Delayed-Release Capsules, USP, 60mg, Rx Only, 1000-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Ongoing

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
51991-746Duloxetine Delayed-ReleaseDuloxetine HydrochlorideCapsule, Delayed Release PelletsOralBreckenridge Pharmaceutical, Inc.Human Prescription Drug
51991-747Duloxetine Delayed-ReleaseDuloxetine HydrochlorideCapsule, Delayed Release PelletsOralBreckenridge Pharmaceutical, Inc.Human Prescription Drug
51991-748Duloxetine Delayed-ReleaseDuloxetine HydrochlorideCapsule, Delayed Release PelletsOralBreckenridge Pharmaceutical, Inc.Human Prescription Drug
51991-750Duloxetine Delayed-ReleaseDuloxetine HydrochlorideCapsule, Delayed Release PelletsOralBreckenridge Pharmaceutical, Inc.Human Prescription Drug